In one of our previous blogs, we wrote about the Five Diagnostics (IVD) Access Challenges & Potential Actions e.g. cost-based reimbursement and lack of clear funding pathways, processes.
To tackle those problems, first, we need to consolidate relevant, available datasets and then we can derive various added-value insights.
Introducing dXpert beta - a free, searchable, multi-country platform that integrates publicly available diagnostics reimbursement tariffs from multiple markets
dXpert is currently in beta mode with the aim to continuously improve the service and add features, supporting you with better diagnostics market access insights.
Please sign up and tell us what you think!
